Home > Boards > US Listed > Biotechs > Vaxart, Inc. (VXRT)

VXRT 2Q18 results—6/30/18 cash=$23.9M:

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 722
Posts 109,341
Boards Moderated 13
Alias Born 09/05/02
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2019 12:20:56 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/8/2019 6:01:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/7/2019 6:14:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/3/2019 6:16:21 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/3/2019 6:01:18 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 10/1/2019 6:07:35 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/30/2019 6:56:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/30/2019 6:50:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/30/2019 6:12:05 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 9/27/2019 4:33:04 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 9/27/2019 4:18:30 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/27/2019 6:01:00 AM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) Edgar (US Regulatory) - 9/25/2019 8:09:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2019 8:06:20 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/24/2019 5:31:09 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/20/2019 5:32:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/19/2019 4:03:41 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/11/2019 5:35:48 PM
Vaxart to Present at the H.C. Wainwright 21st Annual Global Investment Conference Business Wire - 9/4/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2019 4:05:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 4:03:18 PM
Vaxart Announces Second Quarter 2019 Financial Results and Provides Corporate Update Business Wire - 8/8/2019 4:01:00 PM
Vaxart Enters into Research Collaboration with Janssen to Evaluate Oral Universal Influenza Vaccine Business Wire - 7/9/2019 8:00:00 AM
Vaxart to Present at ASM Microbe 2019 Business Wire - 6/20/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/14/2019 5:02:18 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist